Upgrade to SI Premium - Free Trial

Galectin Therapeutics (GALT)

3.19 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Form ARS GALECTIN THERAPEUTICS For: Dec 31 October 13, 2026 8:01 AM - SEC Filing Form DEFA14A GALECTIN THERAPEUTICS October 13, 2026 8:01 AM - SEC Filing Form DEF 14A GALECTIN THERAPEUTICS For: Dec 03 October 13, 2026 8:00 AM - SEC Filing Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026 October 6, 2026 8:00 AM - Globe NewsWire Form PRE 14A GALECTIN THERAPEUTICS For: Dec 03 October 2, 2026 3:54 PM - SEC Filing Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference September 10, 2026 8:00 AM - Globe NewsWire Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update  August 14, 2026 8:00 AM - Globe NewsWire Form 8-K GALECTIN THERAPEUTICS For: Aug 14 August 14, 2026 7:56 AM - SEC Filing Form 10-Q GALECTIN THERAPEUTICS For: Jun 30 August 14, 2026 7:51 AM - SEC Filing Form SCHEDULE 13D/A GALECTIN THERAPEUTICS Filed by: Uihlein Richard E August 4, 2026 8:30 AM - SEC Filing Galectin Therapeutics converts $105.8M in debt to equity August 4, 2026 8:04 AM - StreetInsider Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet August 4, 2026 8:00 AM - Globe NewsWire Form 4 GALECTIN THERAPEUTICS For: Jul 31 Filed by: Uihlein Richard E August 4, 2026 7:52 AM - SEC Filing Form 8-K GALECTIN THERAPEUTICS For: Jul 31 August 4, 2026 7:50 AM - SEC Filing Full Article List